1992
DOI: 10.1016/0022-1759(92)90152-j
|View full text |Cite
|
Sign up to set email alerts
|

A thymosin β4 ELISA using an antibody against the N terminal fragment thymosin β4[1–14]

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0
3

Year Published

1993
1993
2005
2005

Publication Types

Select...
3
3

Relationship

1
5

Authors

Journals

citations
Cited by 22 publications
(12 citation statements)
references
References 12 publications
0
9
0
3
Order By: Relevance
“…We verified the specificity of the ELISA in experiments that showed that high concentrations of another h thymosin protein, Th16/ ThNB [8], which is 90% identical to Th15, were not detected by this assay. Th15 levels recovered from a control urine sample spiked with increasing amounts of synthetic Th15 protein averaged 94%, a level equivalent to those observed in other h thymosin assays [16,17,22,23]. Furthermore, this new ELISA achieved the reliability (demonstrated by the reproducibility of the standard curves) and the speed necessary for testing large numbers of clinical samples.…”
Section: Discussionmentioning
confidence: 60%
See 3 more Smart Citations
“…We verified the specificity of the ELISA in experiments that showed that high concentrations of another h thymosin protein, Th16/ ThNB [8], which is 90% identical to Th15, were not detected by this assay. Th15 levels recovered from a control urine sample spiked with increasing amounts of synthetic Th15 protein averaged 94%, a level equivalent to those observed in other h thymosin assays [16,17,22,23]. Furthermore, this new ELISA achieved the reliability (demonstrated by the reproducibility of the standard curves) and the speed necessary for testing large numbers of clinical samples.…”
Section: Discussionmentioning
confidence: 60%
“…The positions of antibody control, GST-Th15 fusion protein and Th15 are indicated with arrows. Table 4 Demographic and clinical parameters for controls and patients with prostate cancer contrast, antisera raised against intact Th4 or Th9 protein cross-react strongly with other h thymosins, whereas the amino-terminal fragments yield high-titer antiserum with minimal cross-reactivity [16,17,21]. In our study, the aminoterminal fragment (1-12) of Th15 yielded a weak response in the hens and rabbits.…”
Section: Discussionmentioning
confidence: 72%
See 2 more Smart Citations
“…According to the results received from the antigenic index plots (Figures 1, 2), the troponin-T segment 34 -62 should be indeed a peptide fragment, suitable for the development of specific antibodies, recognizing the selected segment as well as the parent protein, as we could demonstrate in the past in connection with the development of specific immunoassays for quantitative determinations of thymosin β 9 [36], thymosin β 4 [37,38], transmembrane glycoprotein gp41 env [39], human relaxin [40] or immunostaining experiments of β-thymosins [41,25]. In our laboratory, solution [42], as well as solid phase [43 -45, 26] peptide syntheses are well established for many years, and improved, highly efficient strategies are available.…”
Section: Synthesis Of Troponin-t Fragment 34 -62mentioning
confidence: 98%